Clinical

Dataset Information

0

Coxib-inhibition of Duodenal Polyp Growth in FAP


ABSTRACT: Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.

DISEASE(S): Duodenal Polyposis,Colorectal Neoplasms,Nasopharyngeal Neoplasms

PROVIDER: 2068021 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2018-02-16 | GSE94919 | GEO
2018-02-27 | GSE111156 | GEO
2023-08-07 | GSE189035 | GEO
| 2206253 | ecrin-mdr-crc
| 2259258 | ecrin-mdr-crc
| PRJNA436023 | ENA
2013-07-15 | E-GEOD-39438 | biostudies-arrayexpress
| 2014598 | ecrin-mdr-crc
| 2065289 | ecrin-mdr-crc
2014-05-01 | E-GEOD-50788 | biostudies-arrayexpress